ABSTRACT Phenotypically nontoxinogenic mutants of Vibrio cholerae were isolated after infection with either of two mutagenic vibriophages, VcAl and VcA2ctsl. DNA isolated from these mutants was analyzed for toxin gene sequences by the Southern blotting method with 32P-labeled probes derived from the cloned A and B subunit genes for the heat-labile enterotoxin ofEscherichia coli, designated LT. Several of the mutant isolates were shown by this method to have lost all sequences hybridizing to the LT probes, indicating that these clones contain deletion mutations that removed the structural gene(s) for cholera toxin.The mutants were prototrophic and grew normally, in vitro, demonstrating that the toxin is not essential for the growth and viability of V. cholerae. Moreover, the toxin gene deletion mutants multiplied well in vivo in ligated rabbit intestine. Because of these growth properties and the stability ofdeletion mutations, these strains are promising candidates for testing as live oral vaccine strains for protection against cholera.
Colonization of the upper bowel of man by toxinogenic Vibrio cholerae, the etiologic agent ofAsiatic cholera, results in a diarrheal syndrome primarily due to the action of cholera toxin, which stimulates fluid secretion by activating adenylate cyclase in intestinal epithelial cells (1) . The toxin is a multimeric protein (Mr, 84,000) composed of one A subunit (Mr, 28 ,000) and five B subunits (Mr, 11,600) (2) . The B subunits mediate binding to ganglioside cell surface receptors and perhaps also facilitate entry ofthe A subunit into the eukaryotic cell (2, 3) . The A subunit promotes the activation of adenylate cyclase in target cells by catalyzing the transfer of the ADP-ribosyl moiety of NAD to a GTPase-regulatory component of the cyclase complex (4, 5) .
Recently, the heat-labile enterotoxin ofEscherichia coli, designated LT, has been shown to be highly similar to cholera toxin in both structure and mode of action (6, 7) . Whereas the LT Aand B-subunit genes have been found to exist on a variety of plasmids, the gene(s) encoding cholera toxin has not been definitely located, although there are data to suggest that it resides on the V. cholerae chromosome (8) (9) (10) . Although several laboratories have reported isolation of toxin (Tox) mutations that affect the production of one or both of the toxin subunits, none ofthese mutants has been shown to produce structurally altered polypeptides (11) (12) (13) (14) (15) (16) (17) .
The isolation of deletion mutations in the toxin structural gene(s) would facilitate its unambiguous genetic mapping. Furthermore, the high stability of deletion mutations would have practical value in the construction of stably attenuated strains of V. cholerae for use as live oral vaccines against cholera. In this study, we report the isolation of deletion mutations in the cholera toxin structural gene. Furthermore, several mutants with complete deletions of the toxin gene(s) exhibit little impairment of growth in adult rabbit intestine. These strains may be useful as stable and safe prototypes for a live oral cholera vaccine.
MATERIALS AND METHODS
Bacterial Strains and Bacteriophage. Wild-type and mutant strains used in this study are listed in Table 1 . Phage VcAl was grown and partially purified as described (20) . Phage VcA2ctsl is a thermoinducible mutant of phage VcA2 (R. H. Hudson and W. R. Romig, personal communication) which displayed better virion stability and plaque morphology than the parental phage (20) .
Mutant Isolation and Toxin Assays. Mutagenesis of strain RV79 with VcAl and VcA2ctsl was performed by preparing a lysogen population from plate lysates (104 plaques per plate) grown at 30°C in Tryptone/yeast extract medium (20) . Colonies from these lysogen populations were screened for loss of toxin production by the ganglioside filter assay (13) or for auxotrophic mutations on M63 minimal medium (21) .
Toxin production in liquid culture was measured with the S49 mouse lymphosarcoma cell assay (15) . Toxin antigen was measured with an enzyme-linked immunosorbent assay performed essentially as described by Harris et al. (22) . Purified cholera toxin (19) served as the standard in the above assays. Toxin production and growth in vivo was assayed by using the ligated intestinal-loop model in rabbits as described (13) . For each strain, approximately 107 cells were injected in a 5-cm intestinal loop; 18 hr later, the loops were scored for fluid accumulation and for viable counts after homogenization of the tissue. Serial passage of bacteria was performed without intermediate culturing of the test strains (e.g., intestine-to-intestine transfer).
DNA Preparation and Analysis. DNA was prepared from bacterial cells by the method of Brenner et aL (23) . DNA was prepared from partially purified phage by extraction with phenol equilibrated with 50 mM Tris/50 mM EDTA, pH 8.0, followed by ethanol precipitation of the aqueous phase. Digestion of bacterial and phage DNA with restriction endonucleases was carried out under the conditions suggested by the manufacturer.
LT sequence probes from plasmid EWD299 (24) were prepared by the methods of Moseley and Falkow (9) . A 1275-basepair HincIl fragment and a 590-base-pair EcoRI-HindIII fragment were used as the LT A-and LT B-subunit sequence probes, respectively. Labeling of these LT fragments and purified VcAl DNA with [32P]dCTP (New England Nuclear) to a specific activity of about 107 cpm/,ug was carried out by nick translation (25) . Electrophoresis in 0.7% agarose gels and Southern blot hybridization was performed as described (9, 26) .
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Recent observations in another laboratory suggested that the V. cholerae bacteriophage VcAl had properties consistent with its being capable of transposition and insertion into many different sites on the V. cholerae chromosome (18) . These properties suggested that VcAl might have biological properties similar to those of bacteriophage Mu in E. coli (27) . Consistent with this prediction, Johnson et aL (28) have recently observed the induction of auxotrophic mutations by VcAl. Independently, we also have observed that both VcAl and VcA2, a serologically related and heteroimmune K-type vibriophage (20) , were capable ofinducing auxotrophic mutations coincident with lysogenization in V. cholerae strain RV79.
Phages VcAl and VcA2ctsl (a thermoinducible mutant of VcA2) induced auxotrophic mutations at frequencies of about 0.6% and 0.2%, respectively, in lysogen populations of RV79 ( Table 2 ). The frequency of spontaneous auxotrophy in untreated cultures was below detectable levels (less than 0.05%). Furthermore, the frequency of auxotrophy induced by both of the two phages increased to about 1-2% when colonies were picked from rich media to minimal plates, suggesting that crossfeeding on the replica plates resulted in failure to identify a large fraction of auxotrophic mutants. Therefore, the frequency of auxotrophy induced by lysogeny with these vibriophages is comparable to that seen with bacteriophage Mu in E. coli (27) .
The variety and multiplicity of auxotrophies observed suggests that these phages are capable of random insertion in the cholera chromosome (18, 29 (28) . Similar analysis of VcA2ctsl mutations has been precluded by our inability to obtain enough sufficiently pure VcA2ctsl DNA to do these experiments.
The high stability observed for both VcAl-and VcA2ctsl-induced mutations is consistent with their being phage Mu-like in nature. No detectable reversion (less than 10-10) of several tested VcAl-or VcA2ctsl-induced auxotrophic mutations was observed, suggesting that these vibriophages-might also resemble wild-type phage Mu in being essentially incapable ofprecise excision (27) .
Isolation of Phage-Induced Nontoxinogenic Mutants of V. cholerae. The high stability of the phage-induced auxotrophic mutations suggested that mutagenesis ofV. cholerae with VcAl and VcA2ctsl might be an excellent means ofgenerating stable mutations in the toxin structural gene. Therefore, VcAl and VcA2ctsl lysogen populations of V. cholerae strain RV79 were screened for nontoxinogenic mutants by the ganglioside filter assay (13) . Phenotypically nontoxinogenic clones were present in VcAl and VcA2ctsl lysogen pools at a frequency of about 0.05%.
Five nontoxinogenic mutants were analyzed for toxin production by the S49 lymphosarcoma cell assay (15) and for toxin antigen production by an enzyme-linked immunosorbent assay (22) . Table 3 shows that no toxin (<1 ng/ml) or toxin antigen (<10 ng/ml) was detectable by either assay in culture supernatant fluids of any of these five mutants. In contrast, the toxin produced by three nitrosoguanidine-induced, hypotoxinogenic mutants (M13, RM3, and RM6) of strain 569B was detected by both assays. Therefore, the phage-induced nontoxinogenic mutants described here are highly defective in production ofactive or immunologically detectable toxin gene products.
Identification of Deletion Mutations in the Cholera Toxin Structural Gene. Moseley and Falkow (9) recently reported that 32P-labeled probes derived from the cloned genes for the LT A and B subunits of E. coli would hybridize to chromosomal fragments of V. cholerae DNA under conditions of reduced stringency. The V. cholerae restriction enzyme fragments showing homology with these LT probes were predicted to be those containing part or all of the structural gene(s) for cholera toxin. We have used these LT A-and B-subunit gene probes to analyze the structure of the cholera toxin gene in RV79 and in the five nontoxinogenic, phage-induced mutants.
Southern blot analysis of HindIll-digested DNA prepared from these strains is shown in Fig. 1 . Unexpectedly, VcAl-induced mutant M7922 and two VcA2ctsl-induced mutants, M7928 and M7930 had lost all detectable sequences hybridizing to the LT A-subunit gene probe. In contrast, VcAl-induced mutant M7923, like the parental strain RV79, displayed a single 20-kilobase fragment that hybridized to the LT A-subunit gene probe. VcA2ctsl-induced mutant M7929 also had lost most of the hybridization signal originally present in RV79 but displayed a weak signal of about 23 kilobases in size.
A similar analysis utilizing the LT B-subunit probe produced the same hybridization signals seen with the A-subunit probe for all strains, with the exception that M7929 was completely unreactive with the LT B-subunit probe (data not shown). This result indicates that, as in the case ofother strains of V. cholerae (9, 10), the DNA sequences coding for cholera toxin's A and B subunits are located within 20 kilobases of each other in strain RV79.
These data indicate that mutants M7922, M7928, and M7930 have deletion mutations that have removed the structural gene(s) coding for cholera toxin. Mutant M7923 may be an insertion ordeletion mutant that has inactivated a toxin regulatory element required for expression of the toxin structural gene(s). These results also suggest that none ofthe toxin mutants appear to have sustained a simple point insertion of either the VcAl or VcA2ctsl prophages into a toxin structural gene. Such an insertion should have manifested itself as a change in the number or molecular weight, or both, of the bands hybridizing to the (26) . The nitrocellulose sheet was then incubated with the 32P-labeled LT-A probe, washed, and autoradiographed as described (9 * Measured in the rabbit ileal loop assay. as described (13) . t The average bacterial cell density attained in 16-18 hr, expressed in colony-forming units x 10 9 per cm of intestine (three determinations). One centimeter of intestine was equivalent to approximately 0.4 g of tissue. $ The average fluid response in 16-18 hr expressed in ml/cm of intestine (three determinations).
after homogenization of the gut tissue. All three toxin deletion mutants multiplied 100-to 1000-fold, attaining average cell densities in vivo of 2-8 x 109 colony forming units per cm of intestine. The three mutants induced no significant fluid accumulation, and, as expected for total toxin gene(s) deletion mutants, they generated no Tox+ revertants detectable by the ganglioside filter assay. In contrast, the parental strain RV79 attained only a 2-to 6-fold higher average cell density than the mutant strains, even though it induced a large secretory response. These experiments suggest that the cholera toxin gene does not play an essential role in the process ofintestinal growth and survival of V. cholerae in this animal model.
DISCUSSION
Mutations altering toxin production in V. cholerae have been described (11) (12) (13) (14) (15) (16) (17) , but their molecular natures have not been determined. Analysis of VcAl-and VcA2ctsl-induced nontoxinogenic mutants of V. cholerae strain RV79 has led us to conclude that several of these clones possess deletion mutations in the structural gene encoding cholera toxin. This definitive demonstration of a deletion mutation of the cholera toxin structural gene will eventually allow us to map genetically the location of the toxin gene in V. cholerae strain RV79. The demonstration that the toxin deletion mutants show no major defect in their ability to grow in the laboratory or in the gut of susceptible animals argues strongly that the cholera toxin gene is nonessential in V. cholerae. Growth defects in other toxin mutant strains, which have been attributed to possible physiological roles for the toxin in V. cholerae (16) , may more likely represent pleiotropic effects of repeated mutagenesis with nitrosoguanidine. Several of the mutations we characterized proved to be complete deletions of the toxin gene. However, we also found that one mutant (M7929) retained some DNA homologous to the LT A-subunit probe but had lost all sequences hybridizing to the LT B-subunit probe. Thus, the methods described here can also be used to construct partial deletions of the toxin gene. Whether these methods are generally applicable to other stains of V. cholerae would depend mainly on the sensitivity ofthese strains to VcAl and VcA2ctsl.
The induction of toxin deletion mutations by the two vibriophages used in this study is curious in the light of the fact that at least one of them (VcAl) is likely to induce mutations by the insertion of its DNA into random sites on the V. cholerae chromosome (26, 28) . The event responsible for deletion ofthe toxin gene(s) concomitant with VcAl and VcA2ctsl lysogenization is at present unclear. Daniell et al. (30) have reported that, approximately 15% of lacZ mutants induced by phage Mu in E. coli repressed for. lac expression were deletion mutations. In contrast, Mu lysogenization concomitant with active transcription ofthe lac operon, produced either by induction with IPTG or through the use of a lacI constitutive mutant, increased the frequency of deletions observed among lacZ.mutations to 57% and 93%, respectively. These-investigators concluded that active transcription oflac reduced the ability ofphage Mu to insert its DNA into the lacZ gene but did not alter its ability to cause complete deletions of this gene. Because RV79 produces toxin in the phage growth medium used here, active transcription of the toxin gene may have similarly interfered with the point insertion of the VcAl and VcA2ctsl phages into this gene(s). As with phage Mu and lac, phage-induced deletion events would then become responsible for a large fraction of the mutations isolated. Experiments are in progress to examine the influence of transcription on the target specificity of VcAl and VcA2ctsl in V. cholerae.
Finally, we have characterized several mutant strains of V cholerae that might have practical value as prototype live oral cholera vaccines. Strains previously developed for this purpose have displayed instability in vivo, as evidenced by the appearance oftoxinogenic revertant clones in the stools ofanimals (12, 13) and human volunteers (31) . The toxin gene deletion mutants described here would be predicted to be stably attenuated because they have lost the genetic information encoding the toxin.
In addition, these deletion mutants can colonize the mucosal surface and multiply within the gut in the rabbit ligated-loop model. It remains to be determined whether the mutants will colonize as well in other animal models in which the gut remains open [e.g., chinchillas (32) ]. Colonization of man by such mutants should induce protective, secretory IgA antibody that would inhibit bacterial attachment to the mucosa, motility, chemotaxis, protease and neuraminidase activity, and other undefined activities required by V. cholerae for virulence (33) (34) (35) . Antitoxin, of course, would not be induced by these mutants. However, the antitoxin role in immunity to cholera is currently in dispute, and it actually may be oflittle protective value (36) . Moreover, in the event that an antitoxin response is a significant component of immunity to cholera, the methods described here could be used to construct strains with deletion mutations in the A-subunit gene that continue to produce the highly antigenic B subunit of the toxin (16 
